MTHFR rs1801133 polymorphism and susceptibility to colorectal cancer in Iranian population: evidence of a case-control study and meta-analysis

Pharmacogenomics. 2016 Nov;17(17):1957-1965. doi: 10.2217/pgs-2016-0048. Epub 2016 Oct 28.

Abstract

Several studies have investigated whether MTHFR rs1801133 polymorphism contributes to risk of colorectal cancer (CRC), however the results are inconclusive.

Aim: The purpose of this study was to investigate this hypothesis in a case-control study and meta-analysis in Iranian population.

Materials & methods: This polymorphism was genotyped in the 2421 subjects (46% CRC patients) from Tehran. Meta-analysis was performed for determining the risk effect size of this polymorphism on CRC.

Results: Both case-control study and meta-analysis showed no association between rs1801133 and CRC risk or its features.

Conclusion: This study failed to identify an association between the rs1801133 and susceptibility to CRC in Iranian population.

Keywords: MTHFR; colorectal cancer; meta-analysis; polymorphism; susceptibility.